GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharmarise Holdings Corp (TSE:2796) » Definitions » Cyclically Adjusted Revenue per Share

Pharmarise Holdings (TSE:2796) Cyclically Adjusted Revenue per Share : 円5,648.97 (As of Feb. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Pharmarise Holdings Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Pharmarise Holdings's adjusted revenue per share for the three months ended in Feb. 2024 was 円1,144.692. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is 円5,648.97 for the trailing ten years ended in Feb. 2024.

During the past 12 months, Pharmarise Holdings's average Cyclically Adjusted Revenue Growth Rate was 2.00% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.50% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Pharmarise Holdings was 3.50% per year. The lowest was 2.50% per year. And the median was 2.60% per year.

As of today (2024-06-19), Pharmarise Holdings's current stock price is 円639.00. Pharmarise Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Feb. 2024 was 円5,648.97. Pharmarise Holdings's Cyclically Adjusted PS Ratio of today is 0.11.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Pharmarise Holdings was 0.16. The lowest was 0.10. And the median was 0.13.


Pharmarise Holdings Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Pharmarise Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmarise Holdings Cyclically Adjusted Revenue per Share Chart

Pharmarise Holdings Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4,958.89 5,044.61 5,092.26 5,353.29 5,590.25

Pharmarise Holdings Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,537.06 5,590.25 5,639.97 5,669.96 5,648.97

Competitive Comparison of Pharmarise Holdings's Cyclically Adjusted Revenue per Share

For the Pharmaceutical Retailers subindustry, Pharmarise Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmarise Holdings's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pharmarise Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Pharmarise Holdings's Cyclically Adjusted PS Ratio falls into.



Pharmarise Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Pharmarise Holdings's adjusted Revenue per Share data for the three months ended in Feb. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Feb. 2024 (Change)*Current CPI (Feb. 2024)
=1144.692/106.9000*106.9000
=1,144.692

Current CPI (Feb. 2024) = 106.9000.

Pharmarise Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201405 1,149.477 98.100 1,252.590
201408 1,049.111 98.300 1,140.895
201411 1,095.691 97.900 1,196.418
201502 1,084.692 97.600 1,188.049
201505 1,122.891 98.700 1,216.181
201508 1,142.339 98.400 1,241.017
201511 1,188.738 98.100 1,295.373
201602 1,481.938 97.800 1,619.828
201605 1,461.045 98.200 1,590.486
201608 1,407.173 97.900 1,536.535
201611 1,389.866 98.600 1,506.863
201702 1,406.793 98.100 1,532.988
201705 1,659.144 98.600 1,798.808
201708 1,504.149 98.500 1,632.422
201711 1,508.574 99.100 1,627.311
201802 1,471.226 99.500 1,580.644
201805 1,507.578 99.300 1,622.962
201808 1,426.043 99.800 1,527.495
201811 1,381.926 100.000 1,477.279
201902 1,390.801 99.700 1,491.240
201905 1,430.365 100.000 1,529.060
201908 1,255.274 100.000 1,341.888
201911 1,087.431 100.500 1,156.680
202002 976.040 100.300 1,040.266
202005 1,336.019 100.100 1,426.778
202008 1,387.740 100.100 1,482.012
202011 1,369.870 99.500 1,471.750
202102 994.017 99.800 1,064.734
202105 1,490.059 99.400 1,602.488
202108 1,405.272 99.700 1,506.756
202111 1,372.928 100.100 1,466.194
202202 1,355.287 100.700 1,438.731
202205 1,393.029 101.800 1,462.817
202208 1,375.067 102.700 1,431.301
202211 1,366.858 103.900 1,406.325
202302 1,377.573 104.000 1,415.986
202305 1,410.991 105.100 1,435.156
202308 1,429.132 105.900 1,442.627
202311 1,148.053 106.900 1,148.053
202402 1,144.692 106.900 1,144.692

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Pharmarise Holdings  (TSE:2796) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Pharmarise Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=639.00/5648.97
=0.11

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Pharmarise Holdings was 0.16. The lowest was 0.10. And the median was 0.13.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Pharmarise Holdings Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Pharmarise Holdings's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmarise Holdings (TSE:2796) Business Description

Traded in Other Exchanges
N/A
Address
8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011
Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.

Pharmarise Holdings (TSE:2796) Headlines

No Headlines